Would you be interested in the Business Strategies, Competitive Strengths and Key Risks?

Log in or Become a UTRADE Client Now

Latest IPO

Competitive Margin Interest Rates $0 Handling Fee on Cash Applications for New Self-Serviced Clients # Login to Subscribe
Planned Offering Offering Closing Date Settlement Refund / Grey Market Trading
2021

AUG

0607080910111213141516171819202122232425
IPO Calendar
Planned IPOs
Stock Offer Period Trading Price(HKD) BoardLot IndicativeInterest Rate UOBKH'sClosing Date Sponsor(s) Oversubscription
IPO Calendar
2015Li Auto - W 03/08/202106/08/2021 12/08/2021 150.0150.0 100 1.60% 05/08/2021

Goldman Sachs

CICC

Day 1:>1.13x

Day 2:>1.57x

Day 3:>2.27x

Planned IPOs *
Cloud Village Passed PHIP on 1 Aug N/A N/A N/A N/A N/A

BofA*

CICC*

Credit Suisse*

-
AInnovation Application Submitted* N/A N/A N/A N/A N/A

UBS*

CICC*

China Renaissance*

-
Imeik Technology Dev N/A Aug* N/A N/A N/A N/A

Morgan Stanley*

CICC*

-
HeartCare Medical Passed PHIP on 25 Jun N/A N/A N/A N/A N/A

Goldman Sachs*

CITIC*

-
Edding Group Passed PHIP on 25 Jun N/A N/A N/A N/A N/A

Morgan Stanley*

Credit Suisse*

-
Acotec Scientific Passed PHIP on 23 Jun N/A N/A N/A N/A N/A

Morgan Stanley*

CICC*

-
Transcenta Passed PHIP on 22 Jun N/A N/A N/A N/A N/A

Goldman Sachs*

CICC*

-
Shanghai Bio-heart Biological Technology Passed PHIP on 16 Jun N/A N/A N/A N/A N/A

Goldman Sachs*

Huatai*

-
eBeauty Passed PHIP on 23 Jun N/A N/A N/A N/A N/A

CITIC*

Credit Suisse*

-
Gu Sheng Tang N/A 2021* N/A N/A N/A N/A

BofA*

Haitong*

-
China Duty Free Group Application Submitted* Q4* N/A N/A N/A N/A

N/A

-
MicroPort MedBot Application Submitted* 2021* N/A N/A N/A N/A

N/A

-
SenseTime N/A End of 2021* N/A N/A N/A N/A

N/A

-
Chief Group Application Submitted* N/A N/A N/A N/A N/A

BOCOM*

-
Konew Financial N/A N/A N/A N/A N/A N/A

CCBI*

-
LexinFintech N/A 2nd half of year* N/A N/A N/A N/A

N/A

-
Top Glove N/A Q3* N/A N/A N/A N/A

CICC*

-
RF China Application Submitted* Q3* N/A N/A N/A N/A

ABCI*

CICC*

-
Fangzhi Group Application Submitted* N/A N/A N/A N/A N/A

CCBI*

-
Wanda Group Sep* N/A N/A N/A N/A N/A

N/A

-
DRC Bank N/A Q3* N/A N/A N/A N/A

CMS*

CMBI*

ABCI*

ICBC*

-
TamJai INTL Application Submitted* N/A N/A N/A N/A N/A

N/A

-
Hanyu Medical Application Submitted* Q3* N/A N/A N/A N/A

CITIC*

Citi*

-
XiaoDian N/A 2021* N/A N/A N/A N/A

N/A

-
GOGOX N/A 2021* N/A N/A N/A N/A

N/A

-
Qdama N/A N/A N/A N/A N/A N/A

N/A

-
Medbanks N/A 2nd half of the year* N/A N/A N/A N/A

Morgan Stanley*

CICC*

Haitong*

-
ESCO N/A Q4* N/A N/A N/A N/A

N/A

-
APM Monaco N/A 2021* N/A N/A N/A N/A

Morgan Stanley*

CICC*

-
Abbisko N/A 2021* N/A N/A N/A N/A

N/A

-
NIO N/A 2021* N/A N/A N/A N/A

Credit Suisse*

Morgan Stanley*

-
YiSheng Biopharma Application Submitted* 2021* N/A N/A N/A N/A

Morgan Stanley*

Haitong*

-
Novotech N/A 2021* N/A N/A N/A N/A

N/A

-
ECARX N/A 2nd half of the year* N/A N/A N/A N/A

Morgan Stanley*

UBS*

-
Weibo N/A 2nd half of the year* N/A N/A N/A N/A

Goldman Sachs*

UBS*

CLSA*

-
Betta Pharmaceuticals Passed PHIP on 30 May N/A N/A N/A N/A N/A

Goldman Sachs*

UBS*

CITIC*

-
Visen Pharma N/A 2021* N/A N/A N/A N/A

Jefferies Group*

Morgan Stanley*

-
Recbio N/A 2021* N/A N/A N/A N/A

N/A

-
Tencent Music N/A This Year* N/A N/A N/A N/A

Morgan Stanley*

JPMorgan*

-
JOYY N/A Q3* N/A N/A N/A N/A

N/A

-
Vipshop N/A Q2* N/A N/A N/A N/A

N/A

-
DIDA CHUXING N/A N/A N/A N/A N/A N/A

Haitong*

Nomura*

-
DiDi N/A Q3* N/A N/A N/A N/A

Goldman Sachs*

-
WeDoctor Application Submitted* 1st half of the year* N/A N/A N/A N/A

Citibank*

CMB INTL*

JPM*

Credit Suisse*

CITIC*

-

# Terms and Conditions Apply

*Market News

:UOB Kay Hian (UOBKH) is one of the participants